Upcoming Events Upcoming Events Featured Events Feb 12, 2024 at 8:00 AM EST Larimar Therapeutics Reports Positive Top-line Data from Phase 2 Dose Exploration Study from 25 mg and 50 mg Cohorts of Nomlabofusp in Patients with Friedreich’s Ataxia Click Here for Webcast Upcoming Events More events are coming soon.
Upcoming Events Featured Events Feb 12, 2024 at 8:00 AM EST Larimar Therapeutics Reports Positive Top-line Data from Phase 2 Dose Exploration Study from 25 mg and 50 mg Cohorts of Nomlabofusp in Patients with Friedreich’s Ataxia Click Here for Webcast Upcoming Events More events are coming soon.
Feb 12, 2024 at 8:00 AM EST Larimar Therapeutics Reports Positive Top-line Data from Phase 2 Dose Exploration Study from 25 mg and 50 mg Cohorts of Nomlabofusp in Patients with Friedreich’s Ataxia Click Here for Webcast